Senseonics SENS 深 滬
等待開盤 09-08 09:30:00 美东时间
9.63
-0.270
-2.73%
華盛通- 最 高9.98
- 今 開9.76
- 成交量 42.56万股
- 最 低 9.62
- 昨 收 9.90
- 總市值 5.09亿
- 52周最高 11.576
- 市盈率 靜 --
- 換手率 0.80%
- 52周最低 4.79
- 委 比 50.00%
- 總股本 5287.41万
- 歷史最高 111.20
- 量 比 0.68
- 振 幅 3.64%
- 歷史最低 4.79
- 每 手 1
- 風險率 1.30%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多These low-priced stocks are flashing overbought signals
Several sub-$10 stocks are flashing elevated momentum signals, with a handful already entering traditionally overbought territory as recent rallies push their Relative Strength Index readings toward t...
09-05 00:19
e.l.f., Senseonics, Dropbox, 3D Systems, Nucor Shake Markets
Insiders have been trading these 5 stocks: (($ELF)), (($SENS)), (($DBX)), (($DD...
08-22 21:01
Senseonics Holdings Raises FY2026 Sales Guidance from $60.000M-$64.000M to $62.000M-$66.000M vs $62.117M Est
Senseonics Holdings (AMEX:SENS) raises FY2026 sales outlook from $60.000 million-$64.000 million to $62.000 million-$66.000 million vs $62.117 million estimate.
08-07 04:09
Senseonics Holdings Q2 EPS $(0.63), Inline, Sales $14.483M Beat $12.871M Estimate
Senseonics Holdings (AMEX:SENS) reported quarterly losses of $(0.63) per share which met the analyst consensus estimate. This is a 57.5 percent decrease over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $14.483 million which beat the analyst con...
08-07 04:03
Senseonics 2026年第二季度财报：营收翻倍，亏损扩大
Senseonics（SENS）2026年第二季度营收1450万美元，同比增长约120%；毛利率升至约59%，但净亏损扩大至3670万美元，公司同时上调全年营收及毛利率指引。
08-06 22:05
美股大行评级 | 潜在涨幅284.62%！Annexon获Needham上调目标价至25美元；多家大行上调美国银行目标价
今日重点评级关注：Needham：维持Annexon"买入"评级，目标价从11美元升至25美元；Benchmark：维持Prenetics Global"买入"评级，目标价从30美元升至40美元
07-16 18:55
Mizuho Maintains Outperform on Senseonics Holdings, Lowers Price Target to $18
Mizuho analyst Anthony Petrone maintains Senseonics Holdings (NASDAQ:SENS) with a Outperform and lowers the price target from $20 to $18.
07-16 02:33
Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems
Eversense 365 CGM system demonstrated superior performance in both open-loop and closed-loop systems, with strong patient adherence and favorable glucometrics over a full year. The system achieved a mean TIR of 66.16% and GMI of 7.16%, outperforming other CGMs. Integration with the twiist AID system showed promising results, with users achieving a mean TIR of 76.08% and GMI of 6.78%. These findings highlight Eversense 365's exceptional accuracy a...
06-06 21:00
Marathon, Coherent, Senseonics, KLA, Zoetis Insider Shakeup
Insiders have been trading these 5 stocks: (($MPC)), (($COHR)), (($SENS)), (($K...
05-16 21:01
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
